Global Prothrombin Complex Concentrate Injection Market Growth 2024-2030

Global Prothrombin Complex Concentrate Injection Market Growth 2024-2030

Factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein.

The global Prothrombin Complex Concentrate Injection market size is projected to grow from US$ 1029 million in 2024 to US$ 2081 million in 2030; it is expected to grow at a CAGR of 12.4% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Prothrombin Complex Concentrate Injection Industry Forecast” looks at past sales and reviews total world Prothrombin Complex Concentrate Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Prothrombin Complex Concentrate Injection sales for 2024 through 2030. With Prothrombin Complex Concentrate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prothrombin Complex Concentrate Injection industry.

This Insight Report provides a comprehensive analysis of the global Prothrombin Complex Concentrate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prothrombin Complex Concentrate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prothrombin Complex Concentrate Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prothrombin Complex Concentrate Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prothrombin Complex Concentrate Injection.

United States market for Prothrombin Complex Concentrate Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Prothrombin Complex Concentrate Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Prothrombin Complex Concentrate Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Prothrombin Complex Concentrate Injection players cover CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Prothrombin Complex Concentrate Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other

Segmentation by Application:
Hemophilia B
Acquired Coagulation Factor Deficiency

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda

Key Questions Addressed in this Report

What is the 10-year outlook for the global Prothrombin Complex Concentrate Injection market?

What factors are driving Prothrombin Complex Concentrate Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Prothrombin Complex Concentrate Injection market opportunities vary by end market size?

How does Prothrombin Complex Concentrate Injection break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.